MedPath

Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer

Not Applicable
Conditions
Breast Cancer
Registration Number
NCT00538395
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Brief Summary

Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients with locally advanced breast cancer
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Effectivenessoverall
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath